Fact CheckerSign in

NCT03640325Completed

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Source: ClinicalTrials.gov · Last updated 26 Oct 2024

Brief summary (registry, in English)

Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.

Status (registry)
Completed
Study type
Interventional
Enrollment
143 (actual)
First submitted
15 Aug 2018
Start date
1 Apr 2019
Primary completion date
31 Mar 2023
Lead sponsor
Seattle Children's Hospital
NCT number
NCT03640325

What you commit to

  • Study type: Interventional
  • Participants enrolled: 143
  • From 1 Apr 2019 to the primary completion date, 31 Mar 2023
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Unable to read English or Spanish
    • For enrolled caregivers of AYA patient (no age limit):

Other

  • Patient refusal
  • Cognitively or physically unable to participate in interviews
  • Unable to speak English

Who the study is looking for

  • Patient aged 12-24 years
  • Receiving hematopoietic cell transplantation (HCT) for malignancy or cancer predisposition syndrome
  • Within 4 weeks of HCT "day zero"
  • Able to speak English
  • Able to read English or Spanish
  • Cognitively able to participate in interviews
  • AYA Child of caregiver agreed to participate
  • One caregiver per patient-caregiver dyad
  • Parent/guardian cognitively and physically able to participate
  • Parent/guardian is able to speak/read English or Spanish

Age in the registry: 12 years to 24 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesUnknown status
Dana-Farber Harvard Cancer Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Children's Hospital of Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
St. Jude Children's Research Hospital
Coordinator of this site? Confirm its status
MemphisUnited StatesUnknown status
Seattle Children's Hospital Cancer and Blood Disorders Center
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.